Photodynamic therapy of early esophageal cancer

Summary In 1992–2006 at P.A. Hertsen Moscow Oncology Research Institute photodynamic therapy (PDT) was performed in 48 esophageal cancer patients (total 48 lesions). For PDT we used Russian photosensitizers (Photogem, Photosens, Radachlorin, Alasens), Russian diode lasers (Crystall) and endoscopic e...

Full description

Saved in:
Bibliographic Details
Published inPhotodiagnosis and photodynamic therapy Vol. 5; no. 3; pp. 187 - 190
Main Authors Filonenko, Elena V., MD, Sokolov, Victor V, Chissov, Valery I, Lukyanets, Evgeny A, Vorozhtsov, Georgy N
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2008
Subjects
Adult
Aged
Aged, 80 and over
Early esophageal cancer
Esophageal Neoplasms - drug therapy
Female
Hematology, Oncology and Palliative Medicine
Humans
Internal Medicine
Male
Middle Aged
Photochemotherapy
Photodynamic therapy
Photosensitizers
Treatment Outcome
Early esophageal cancer
Photodynamic therapy
Photosensitizers
Online AccessGet full text

Cover

More Information
Summary:Summary In 1992–2006 at P.A. Hertsen Moscow Oncology Research Institute photodynamic therapy (PDT) was performed in 48 esophageal cancer patients (total 48 lesions). For PDT we used Russian photosensitizers (Photogem, Photosens, Radachlorin, Alasens), Russian diode lasers (Crystall) and endoscopic equipment. As a result of PDT complete regression was in 77% of esophageal cancer lesions, partial regression was in 23%. The follow-up period was 3–11 years. Median of survival was in 4.59 years of esophageal cancer patient.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1572-1000
1873-1597
DOI:10.1016/j.pdpdt.2008.06.001